Skip to main content

Want a detailed portfolio tracker?

LAVA Therapeutics (LVTX) Free Cash Flow (2024 - 2025)

LAVA Therapeutics (LVTX) free cash flow from Mar 31, 2024 to Sep 30, 2025. The TTM LAVA Therapeutics (LVTX) free cash flow is -$31M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual Free Cash Flow

Quarterly Free Cash Flow

LAVA Therapeutics (LVTX) Free Cash Flow CAGR table

PeriodCAGR
1 Year TTM+60.99%

Annual Free Cash Flow change of LAVA Therapeutics (LVTX)

YearFree Cash FlowChange
2025-$30M+54.70%
2024-$20M-52.30%
2023-$41M-1115.10%
2022$4.04M-114.10%
2021-$29M+207.73%
2020-$9.31M+8.13%
2019-$8.61MN/A